Genomics

Dataset Information

Identification of formononetin as the active compound of CR-SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co-expression networks


ABSTRACT: Identification of formononetin as the active compound of CR-SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co-expression networks

PROVIDER: PRJNA867348 | ENA |

REPOSITORIES: ENA